2,506 Shares in The Cigna Group (NYSE:CI) Acquired by Campbell & CO Investment Adviser LLC

Campbell & CO Investment Adviser LLC bought a new position in shares of The Cigna Group (NYSE:CIFree Report) in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm bought 2,506 shares of the health services provider’s stock, valued at approximately $717,000.

A number of other hedge funds have also bought and sold shares of the company. Osaic Holdings Inc. boosted its holdings in The Cigna Group by 24.8% during the second quarter. Osaic Holdings Inc. now owns 85,852 shares of the health services provider’s stock worth $19,853,000 after purchasing an additional 17,044 shares during the last quarter. TimesSquare Capital Management LLC purchased a new position in The Cigna Group during the second quarter worth about $645,000. Princeton Global Asset Management LLC boosted its holdings in The Cigna Group by 5.1% during the second quarter. Princeton Global Asset Management LLC now owns 2,656 shares of the health services provider’s stock worth $745,000 after purchasing an additional 128 shares during the last quarter. Aristotle Atlantic Partners LLC boosted its holdings in The Cigna Group by 24.3% during the second quarter. Aristotle Atlantic Partners LLC now owns 112,541 shares of the health services provider’s stock worth $31,579,000 after purchasing an additional 22,014 shares during the last quarter. Finally, Rhenman & Partners Asset Management AB boosted its holdings in The Cigna Group by 36.1% during the second quarter. Rhenman & Partners Asset Management AB now owns 114,985 shares of the health services provider’s stock worth $32,265,000 after purchasing an additional 30,485 shares during the last quarter. Institutional investors own 85.32% of the company’s stock.

Insider Buying and Selling at The Cigna Group

In other news, SVP Hoeltzel Mary T. Agoglia sold 4,867 shares of the business’s stock in a transaction on Wednesday, February 7th. The shares were sold at an average price of $330.48, for a total value of $1,608,446.16. Following the transaction, the senior vice president now owns 2,102 shares of the company’s stock, valued at $694,668.96. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 0.60% of the company’s stock.

Wall Street Analyst Weigh In

CI has been the topic of several research reports. Sanford C. Bernstein raised shares of The Cigna Group from a “market perform” rating to an “outperform” rating and lifted their price objective for the stock from $330.00 to $372.00 in a research report on Thursday, January 4th. Royal Bank of Canada raised shares of The Cigna Group from a “sector perform” rating to an “outperform” rating and lifted their price objective for the stock from $327.00 to $354.00 in a research report on Monday, February 5th. StockNews.com raised shares of The Cigna Group from a “buy” rating to a “strong-buy” rating in a research report on Friday, November 3rd. Cantor Fitzgerald raised shares of The Cigna Group from a “neutral” rating to an “overweight” rating and lifted their price objective for the stock from $334.00 to $372.00 in a research report on Monday, February 5th. Finally, Deutsche Bank Aktiengesellschaft raised shares of The Cigna Group from a “hold” rating to a “buy” rating and boosted their price target for the company from $355.00 to $370.00 in a research report on Thursday, February 1st. Two research analysts have rated the stock with a hold rating, ten have assigned a buy rating and two have assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Buy” and an average price target of $357.15.

Read Our Latest Stock Report on The Cigna Group

The Cigna Group Stock Performance

Shares of CI stock opened at $334.93 on Friday. The Cigna Group has a one year low of $240.50 and a one year high of $335.83. The company’s 50-day moving average is $301.06 and its 200 day moving average is $293.76. The company has a market capitalization of $98.01 billion, a price-to-earnings ratio of 19.26, a price-to-earnings-growth ratio of 1.03 and a beta of 0.51. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.71 and a current ratio of 0.67.

The Cigna Group (NYSE:CIGet Free Report) last announced its quarterly earnings results on Friday, February 2nd. The health services provider reported $6.79 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.54 by $0.25. The firm had revenue of $51.15 billion for the quarter, compared to the consensus estimate of $48.91 billion. The Cigna Group had a net margin of 2.64% and a return on equity of 13.59%. The business’s quarterly revenue was up 11.8% compared to the same quarter last year. During the same quarter last year, the firm posted $4.96 EPS. Sell-side analysts expect that The Cigna Group will post 28.36 EPS for the current fiscal year.

The Cigna Group Increases Dividend

The company also recently declared a quarterly dividend, which will be paid on Thursday, March 21st. Shareholders of record on Wednesday, March 6th will be issued a dividend of $1.40 per share. The ex-dividend date is Tuesday, March 5th. This represents a $5.60 annualized dividend and a yield of 1.67%. This is an increase from The Cigna Group’s previous quarterly dividend of $1.23. The Cigna Group’s payout ratio is currently 28.29%.

The Cigna Group Company Profile

(Free Report)

The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.

Featured Articles

Institutional Ownership by Quarter for The Cigna Group (NYSE:CI)

Receive News & Ratings for The Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.